ARCHIVES

Drug Approved in Europe For Pediatric Cancer Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

NCI Advisory Group, other Cancer Meetings

July 29, 1988

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001